menu
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Technology
DNase I Oncology Platform
Publications
Pipeline
Overview
XBIO-015
XBIO-020
News & Media
Press Releases
Presentations
Multimedia
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
Proxy Materials
SEC Filings
Corporate Governance
Contact
Xenetic Biosciences, Inc. on Twitter
Xenetic Biosciences, Inc. on Facebook
Xenetic Biosciences, Inc. on LinkedIn
Nasdaq: XBIO
Investors
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Information
Profile
Presentations
Management Team
Contacts
FAQ
Financial Information
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Proxy Materials
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Press Releases
All News
2023
2022
2021
2020
2019
2017
2016
2015
2014
Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer
Jan 4, 2017
Xenetic Biosciences to Present at Biotech Showcase 2017
Jan 3, 2017
« Previous
1
2
3
Get Email Alerts
Stay informed about our latest news and updates
Sign up Today
